PHARMACY COUNCIL OF INDIA IS THE SUPREME AUTHORITY: SC in a landmark judgment

The Supreme Court of India in its landmark judgment has ordered that the Pharmacy Council of India is the supreme authority to regulate pharmacy education and for approval of pharmacy courses and institutions in the country. The court further held that pharmacy education in the country should be governed by the Pharmacy Act, 1948, and dual regulation of pharmacy colleges needs to be ended forthwith and the AICTE Act governing the general technical education would be amended to delete ‘pharmacy’ from its mandate.

The apex court also held that both the Pharmacy Act and the PCI, the statutory body constituted under it, will prevail as far as the recognition of degrees and diplomas of pharmacy education is concerned. As per the Supreme Court order, the norms and regulations set by the PCI and other specified authorities under the Pharmacy Act should be followed by any institution imparting education for degrees and diplomas in pharmacy. After detailed examination of a bunch of petitions on the difficulties faced by pharmacy institutions due to dual regulations by PCI and AICTE, the court found that both the Pharmacy Act, 1948 and the AICTE Act, 1987, contain the provisions regarding pharmacy education leading to duplication of regulations and considerable confusion at the field level.

A three judges bench unanimously decided that this dual regulation should be ended forthwith and the AICTE Act governing the general technical education would be amended deleting ‘pharmacy’ from its mandate and the pharmacy education would thereafter be governed by the Pharmacy Act, 1948.

The Supreme Court’s decision is a welcome move in a right direction as there is definitely need for a stand-alone body like the PCI which comprehends the nuances of curriculum update in a fast transforming industrial environment in the pharmaceutical world.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore